Introduction
Satellite RNAs are small RNA molecules which are completely dependent on coinfection with helper viruses for their replication and encapsidation (Francki, 1985) . Satellite RNAs of cucumber mosaic virus (CMV) can influence the symptoms induced by their helper CMV infection in certain host plants; the type of symptom modification is an inherent property of a particular satellite RNA. Some satellite RNAs attenuate the symptoms induced by CMV (Waterworth et al., 1979; Mossop & Francki, 1979) , whereas others elicit new symptoms that are quite different from those caused by the helper virus (Kaper & Waterworth, 1977; Waterworth et al., 1979; Jacquemond & Lot, 1981 ; Takanami, 1981; Gonsalves et al., 1982) . Symptom modification also depends on the host plant (Waterworth et al., 1979; Jacquemond & Leroux, 1982; Masuta et al., 1988) and helper virus strain (Palukaitis, 1988; Sleat & Palukaitis, 1990a; Jaegle et al., 1990) .
We have been studying the molecular basis of the symptom modification induced by Y satellite RNA (YsatRNA), which causes bright yellow mosaic symptoms on tobacco and systemic necrosis on tomato (Takanami, 1981) , although Kaper et al. (1986) have reported that it does not induce necrosis on tomato. Earlier studies indicated that a domain controlling necrosis on tomato is located within the 3' half of the satellite RNA (Kurath & Palukaitis, 1989; Masuta & Takanami, 1989; Devic et al., 1989) ; the necrogenic consensus sequence has been confirmed by site-directed mutagenesis (Masuta & Takanami, 1989; Devic et al., 1990; Sleat & Palukaitis, 1990b) . It has been shown that the 5' half (Devic et al., 1989) or a central part (Masuta & Takanami, 1989; Jaegle et al., 1990) of Y-satRNA directs yellow mosaic induction on tobacco.
In this paper, we describe further analysis of the domain controlling the yellow mosaic phenotype by making chimeric and mutated satellite RNAs from YsatRNA and S19 satellite RNA (S 19-satRNA), the latter of which does not induce the yellow mosaic phenotype despite considerable sequence identity with Y-satRNA (Masuta & Takanami, 1989; Masuta et al., 1990) .
Methods
Virus strain, satellite RNAs and cDNA clones. CMV-O (Hidaka & Tomaru, 1960 ) was used as a helper virus throughout this study. The origin of the satellite RNAs has been described previously (Takanami, 1981 ; Masuta & Takanami, 1989) , as has a cDNA clone, pUT118GG-S, from which infectious Y-satRNA could be transcribed . A cDNA clone, pS19-sat, from which infectious S19-satRNA could be obtained was produced by the method described previously .
Construction of chimeric and mutated forms of satellite RNA.
Chimeric cDNAs containing the Y-satRNA and S19-satRNA sequences were constructed from pUT118GG-S and pSl9-sat using common cleavage sites for BstXI and NheI (Fig. 1 ). Mutations were introduced by oligonucleotide-directed mutagenesis, as described by Kunkel (1985) , using the following oligonucleotides: dACGATGGTGGGAGTCAC-
for MY5, dTTTTCAGCTCTGCTGCTCTCATTTGATCC for MY6 and dTTTTCAGCTCTGCATTI'CTCATTTGAGCCC for MS1 (mutations are shown in italics).
Assessment of biological activity of clones. EcoRI-linearized eDNA clones were transcribed using T7 RNA polymerase (Pharmacia) as described . A transcription mixture containing approximately 20ttg/ml transcript was inoculated together with 20 ttg/ml of CMV-O onto 1.5-month-old tobacco (Nicotiana tobacum cv. Xanthi-nc) seedlings. For each transcript, six tobacco plants were inoculated in at least two independent experiments. Symptoms were noted 2 to 3 weeks after inoculation, and the accumulation of singleand double-stranded satellite RNAs was confirmed by agarose gel electrophoresis (Masuta et al., 1990) .
Cloning and sequencing of progeny satellite RNA molecules. Total nucleic acid was extracted from two leaves from different tobacco plants and separated on a 2 ~ agarose gel. The band containing progeny satellite RNA was excised from the gel and RNA was recovered by centrifugation using Ultrafree C3 HV (Millipore). Progeny satellite RNA was annealed with an oligonucleotide, dCCCCAAGCITGGGTCCTGTAGAGGAATGT, which is complementary to 19 nucleotides (italics) at the 3" end of the satellite RNA and contains a 3' non-viral extension of 10 nucleotides to create a HindIII site (bold) for cloning, and first-strand DNA was synthesized using Moloney murine leukaemia virus reverse transcriptase (Bethesda Research Laboratories). After the template RNA had been digested with RNase A, second-strand DNA was synthesized using the Klenow fragment of DNA polymerase I (Takara) using the oligonueleotide dCCCCGAATFCGTTTTGTTTGATGGAGAA, which is complementary to the 5' 18 nucleotides of the full-length first-strand DNA (italics) and contains an EcoRl site (bold), as a primer. The resulting doublestranded DNA was digested with EcoRl and HindlII, and then cloned between the EcoRI and HindlII sites of pBluescript II SK(+) (Stratagene). At least three independent clones from each progeny satellite RNA were sequenced using an automated sequencing system, Genesis 2000 (DuPont).
Results and Discussion

Biological activity of chimeric satellite RNAs in tobacco
The sequences of the two independent full-length cDNA clones of S19-satRNA were identical and differed at six positions from the sequence of S19-satRNA published previously (Masuta & Takanami, 1989) ; there were a nucleotide deletion at position 191, insertion of a C residue at position 120, and nucleotide changes at positions 24 (U to C), 25 (A to G), 32 (U to A) and 58 (C to A). As shown in Fig. 1 , the major difference between Y-satRNA and S 19-satRNA was in the central part of YsatRNA (positions 100 to 200), designated region Y (Masuta & Takanami, 1989 To localize the active domain(s) in Y-satRNA that induces the brilliant yellow mosaic symptoms, we constructed chimeric forms of satellite RNA molecules from infectious pUTll8GG-S and pS19-sat clones in vitro by exchanging the BstXI-NheI fragments (Fig. 2) . The transcribed chimeric satellite RNAs with the BstXI-NheI fragment derived from either Y-satRNA or SI9-satRNA were designated 19B,YN19 or YBsl9NY-All tobacco plants inoculated with 19B,YN 19 in the presence of CMV-O showed yellow mosaic symptoms indistinguishable from those of tobacco plants inoculated with Y-satRNA. By contrast, all the tobacco plants inoculated with YB~19NY exhibited attenuated green mosaic symptoms ( Fig. 2 and 3) . Gel electrophoretic analysis of the progeny satellite RNAs indicated that the chimeric satellite RNAs accumulated to the same level as the parental satellite RNAs (data not shown). Sequencing three cDNA clones of the progeny satellite RNA of each chimera confirmed that the parental chimeric satellite RNAs had been exactly reproduced. M u t a n t P h e n o t y p e The results demonstrate that exchange of the BstXINheI fragments of Y-satRNA and S19-satRNA reciprocally alters the phenotypes of the two satellite RNAs. In addition, we have identified the domain responsible for induction of the yellow mosaic phenotype as being contained within the BstXI-NheI fragment (nucleotides 154 to 219) rather than the BstXI-AsulI fragment (154 to 260) (Masuta & Takanami, 1989) , which eliminates the possibility that the three sequence differences found between the NheI and AsulI sites of the two satellite RNAs could be involved. Jaegle et al. (1990) also have reported that the domain responsible for induction of the yellow mosaic phenotype is in the DdeI-NheI fragment (nucleotides 81 to 219) by making chimeras using YsatRNA and I17N' satellite RNA.
Biological activity of mutated forms of Y-satRNA and S19-satRNA in tobacco
Various mutations were introduced in the BstXI-NheI fragment of Y-satRNA and S19-satRNA, in which 14 nucleotide differences were present, to define the yellow mosaic determinant (Fig. 4) . Mutants MY 1 to MY6 were derived from Y-satRNA, MS1 was a derivative of S19-satRNA.
MY1 and MY2 were designed to examine the possibility that the stability of the putative secondary structure in the Y-satRNA (Hidaka et al., 1988) might correlate with yellow mosaic symptom induction, as suggested by Masuta & Takanami (1989) . MY1, which mimics the part I stem structure of the chimeric satellite YBsl9AY (Masuta & Takanami, 1989) , showed the yellow mosaic phenotype on tobacco (Fig. 5) . Furthermore, MY2, into which a mutation was introduced to disrupt the putative part I stem structure, caused yellow mosaic symptoms on tobacco (Fig. 5) . Therefore, the putative secondary structure does not seem to be involved in the induction of the yellow mosaic phenotype. Masuta & Takanami (1989) have introduced two mutations into Y-satRNA, a G residue insertion at position 158 and a point mutation at position 161 (U to C), proving that they do not affect the ability to elicit yellow mosaic symptoms. Mutants MY3 and MY4 contained modifications of the downstream regions of the putative stem (positions 168 to 178 for MY3; 166 to 178 for MY4) and mimic the S 19-satRNA sequence (Fig.  4) . Tobacco plants inoculated with MY3 or MY4 developed yellow mosaic symptoms (Fig. 5) . Of the 14 nucleotide differences in the BstXI-NheI fragments of the satellite RNAs, 11 were shown not to be related to the induction of the yellow mosaic phenotype. Thus, the three nucleotides at positions 191 to 193 of Y-satRNA are the possible candidates for the function of directing the induction of the yellow mosaic phenotype. Based on the results described above, MY5 and MY6 were designed so that the nucleotides at positions 191 to 193 in the 3' region of the BstXI-NheI fragment of YsatRNA mimic the sequences of S19-satRNA and T43-satRNA (Masuta et al., 1990) , respectively. MY5 produced attenuated green mosaic symptoms on tobacco (Fig. 4 and 5) , and MY6 also showed a green mosaic phenotype (Fig. 4) . These mutants clearly demonstrated that the sequence from positions 191 to 193 in Y-satRNA is important for eliciting yellow mosaic symptoms on tobacco. This finding, therefore, extends our previous work (Masuta & Takanami, 1989 ) and the work of Jaegle et al. (1990) .
To confirm the importance of the sequence from positions 191 to 193 in Y-satRNA, we tried to introduce the ability to elicit yellow mosaic symptoms into S19- (Fig. 4) . Tobacco plants inoculated with MS1 showed brilliant yellow mosaic symptoms which were indistinguishable from those induced by Y-satRNA (Fig. 5) . It is surprising that S19-satRNA, which does not induce yellowing, could be converted to a yellow mosaic-inducing satellite R N A by changing a few nucleotides in this region. The results with mutants MYS, MY6 and MS1 lead to the conclusion that nucleotides 191 to 193 of Y-satRNA, and 192 and 193 of S19-satRNA, can reciprocally alter the phenotypes of the two natural satellite RNAs.
Although the actual boundary of the domain for induction of yellow mosaic has not been determined in these experiments because we have modified only a part of the sequences of Y-satRNA and S19-satRNA so that they mimic each other, the available data show that the sequence in the vicinity of nucleotides 178 to 193 in YsatRNA is functionally involved in the induction of yellow mosaic symptoms (see Fig. 4 ). This is partly supported by the work of J aegle et al. (1990) , in which an alteration of nucleotides 185 and/or 186 has been shown to affect the yellow mosaic-inducing ability of YsatRNA.
It has been reported that some mutations introduced into satellite R N A completely abolish biological function and, in some cases, secondary mutations arise in progeny satellite R N A (Collmer & Kaper, 1988; Masuta & Takanami, 1989; Devic et ak, 1990; Jaegle et al., 1990) . All the mutated satellite RNAs we have created here are infectious and the levels to which they accumulate in tobacco are almost the same as those of the authentic satellite RNAs. Moreoever, we have not observed any secondary mutations in any of the progeny satellite RNAs. This may be due to our strategy in which mutations are introduced in two very similar satellite RNAs. Since they are of similar length and are about 90% identical, mutated forms of satellite R N A could retain essential structures or intramolecular interactions for replication.
